Speaker Details

Andrea Tesvich Murina, MD, FAAD

Andrea Tesvich Murina, MD, FAAD

SESSIONS

F013 How to Approach Challenges in Hidradenitis Suppurativa Management: Strategies to Optimize Use of HS Therapies
Mar 8, 2024 • 9:00 AM - 11:00 AM • Room 1B
U016 Combining Systemic Therapies: Should You Do It?
Mar 8, 2024 • 4:30 PM - 5:30 PM • Room 23C

HANDOUTS

Login to view handouts

DISCLOSURES

AbbVie – Speaker(Honoraria); Amgen – Speaker(Honoraria); Bristol-Myers Squibb – Speaker(Honoraria); Eli Lilly and Company – Speaker(Honoraria); Galderma – Speaker(Honoraria); Janssen Biotech – Speaker(Honoraria); Janssen Pharmaceuticals, Inc – Advisory Board(Honoraria); Novartis – Advisory Board(Honoraria); Ortho Dermatologics – Advisory Board(Honoraria), Speaker(Honoraria); Pfizer Inc. – Speaker(Honoraria); Takeda Pharmaceuticals USA Inc – Advisory Board(Honoraria); UCB – Advisory Board(Honoraria); UCB Pharma – Speaker(Honoraria);